Metabolic imaging for gamete and embryo assessment through advanced microscopy technologies: a novel avenue for artificial intelligence?
Open Access
- 15 July 2026
- journal article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 41 (9) , 1470-1481
Abstract
Infertility affects approximately one in six people globally and demand for ARTs, is expected to rise as parenthood is increasingly delayed. However, ART success remains constrained by gamete and embryo quality, female age, and biological factors beyond chromosomal status alone, highlighting the need for non-invasive methods that can complement current morphology-based and genetic approaches. Because gamete and embryo developmental competence is tightly coupled to cellular metabolism, label-free metabolic imaging has emerged as a promising strategy to assess developmental potential through endogenous autofluorescence of reduced nicotinamide adenine dinucleotide/phosphate [NAD(P)H] and oxidized flavins (FAD), which provide optical proxies of redox balance, mitochondrial activity, and oxidative metabolism. This invited mini-review synthesizes the biochemical basis of NAD(P)H/FAD autofluorescence signals, relates these readouts to the unique metabolic programs of oocytes, embryos across preimplantation development, and sperm, and reviews reproductive studies using fluorescence lifetime imaging microscopy, hyperspectral microscopy, and emerging light-sheet fluorescence microscopy. We discuss practical and interpretive challenges, including modality-dependent signal biases and recent consensus efforts towards standardization. Evidence linking metabolic signatures to reproductive ageing, developmental potential, and embryo ploidy status suggests that metabolic imaging, particularly when paired with artificial intelligence (AI), could enable automated, objective decision support for gamete and embryo selection. Finally, we briefly outline how AI could convert complex metabolic imaging data into clinically interpretable decision-support outputs for embryo ranking and risk stratification. Advances in rapid volumetric imaging, microsystems, and AI may support future ART workflows aimed at improving efficiency, accessibility, and cost-effectiveness.Keywords
This publication has 97 references indexed in Scilit:
- PGT-A: what’s it for, what’s wrong?Journal of Assisted Reproduction and Genetics, 2025
- Sperm MetabolismMolecular Reproduction and Development, 2024
- Single cell, Label free Characterisation of Human Mesenchymal Stromal cell Stemness and Future Growth Potential by Autofluorescence Multispectral ImagingStem Cell Reviews and Reports, 2024
- AutoMitoNetwork: Software for analyzing mitochondrial networks in autofluorescence images to enable label‐free cell classificationCytometry Part A, 2024
- Towards label‐free non‐invasive autofluorescence multispectral imaging for melanoma diagnosisJournal of Biophotonics, 2024
- Calcium chloride dihydrate supplementation at ICSI improves fertilization and pregnancy rates in patients with previous low fertilization: a retrospective paired treatment cycle studyJournal of Assisted Reproduction and Genetics, 2022
- Multispectral autofluorescence characteristics of reproductive aging in old and young mouse oocytesBiogerontology, 2022
- Ageing and ovarian stimulation modulate the relative levels of transcript abundance of oocyte DNA repair genes during the germinal vesicle-metaphase II transition in miceJournal of Assisted Reproduction and Genetics, 2020
- Autofluorescence Spectroscopy for Monitoring Metabolism in Animal Cells and Tissues2017
- Transition from maternal to embryonic control in early mammalian development: A comparison of several speciesMolecular Reproduction and Development, 1990